Arca Biopharma reported $-5676000 in Net Income for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Amgen AMGN:US USD 2.14B 826M
Arca Biopharma ABIO:US USD -5676000 1.58M
Biogen BIIB:US USD 1.13B 76.7M
Brainstorm Cell Therapeutics BCLI:US USD -6858000 183K
Bristol Myers Squibb BMY:US USD 1.61B 185M
Cytokinetics CYTK:US USD -142310000 122.49M
Cytrx CYTR:US USD -1295910 7.73M
Daiichi Sankyo 4568:JP JPY 39.46B 20.6B
Gilead Sciences GILD:US USD 1.79B 645M
GlaxoSmithKline GSK:LN GBP 10.32B 9.48B
Laboratory Of America LH:US USD 352.8M 5.8M
Myriad Genetics MYGN:US USD -35100000 21M
Otsuka Holdings 4578:JP JPY 41.28B 5.22B
Pfizer PFE:US USD 8.61B 1.3B
United Therapeutics UTHR:US USD 239.3M 123.3M